IDEXX Laboratories (FRA:IX1) Cyclically Adjusted Book per Share: €7.26 (As of Mar. 2026)


FRA:IX1 IDEXX Laboratories Inc FRA:IX1
96 GF Score
Price €469.00
GF Value €562.69
Valuation Modestly Undervalued
View Full Analysis

What is IDEXX Laboratories Cyclically Adjusted Book per Share?

IDEXX Laboratories FRA:IX1 -0.11% 96 Cyclically Adjusted Book per Share is €7.26 as of Mar. 2026. GuruFocus rates FRA:IX1 with a GF Score™ of 96/100 and a GF Value™ of €562.69 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

IDEXX Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was €16.987. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.26 for the trailing ten years ended in Mar. 2026.

During the past 12 months, IDEXX Laboratories's average Cyclically Adjusted Book Growth Rate was 36.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 34.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 24.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of IDEXX Laboratories was 34.60% per year. The lowest was -10.30% per year. And the median was 6.30% per year.

As of today (2026-07-01), IDEXX Laboratories's current stock price is €469.00. IDEXX Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €7.26. IDEXX Laboratories's Cyclically Adjusted PB Ratio of today is 64.60.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of IDEXX Laboratories was 246.01. The lowest was 23.79. And the median was 97.84.


IDEXX Laboratories  (FRA:IX1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

IDEXX Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=469.00/7.26
=64.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of IDEXX Laboratories was 246.01. The lowest was 23.79. And the median was 97.84.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


IDEXX Laboratories Cyclically Adjusted Book per Share Related Terms


IDEXX Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Cyclically Adjusted Book per Share Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.65 2.96 3.61 5.37 6.62

IDEXX Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.58 5.61 6.02 6.62 7.26

FRA:IX1 vs A, NTRA, WAT: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted PB Ratio falls into.


FRA:IX1
96GF Score
IDEXX Laboratories Inc FRA:IX1
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDEXX Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=16.987/330.2130*330.2130
=16.987

Current CPI (Mar. 2026) = 330.2130.

IDEXX Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.086 241.018 -0.118
201609 0.545 241.428 0.745
201612 -1.168 241.432 -1.598
201703 -0.788 243.801 -1.067
201706 -0.879 244.955 -1.185
201709 -0.467 246.819 -0.625
201712 -0.525 246.524 -0.703
201803 -0.459 249.554 -0.607
201806 -0.406 251.989 -0.532
201809 -0.016 252.439 -0.021
201812 -0.097 251.233 -0.127
201903 0.530 254.202 0.688
201906 1.760 256.143 2.269
201909 2.140 256.759 2.752
201912 1.869 256.974 2.402
202003 1.147 258.115 1.467
202006 2.850 257.797 3.651
202009 4.385 260.280 5.563
202012 6.081 260.474 7.709
202103 6.915 264.877 8.621
202106 7.291 271.696 8.861
202109 7.558 274.310 9.098
202112 7.221 278.802 8.553
202203 6.902 287.504 7.927
202206 5.182 296.311 5.775
202209 5.793 296.808 6.445
202212 6.932 296.797 7.712
202303 9.465 301.836 10.355
202306 12.155 305.109 13.155
202309 14.635 307.789 15.701
202312 16.395 306.746 17.649
202403 17.417 312.332 18.414
202406 17.800 314.175 18.709
202409 17.771 315.301 18.611
202412 18.670 315.605 19.534
202503 16.589 319.799 17.129
202506 15.780 322.561 16.154
202509 16.627 324.800 16.904
202512 17.199 324.054 17.526
202603 16.987 330.213 16.987

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €7.26 mean?
IDEXX Laboratories (FRA:IX1) has a Cyclically Adjusted Book per Share of €7.26 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on IDEXX Laboratories and its competitors.
Is IDEXX Laboratories' Cyclically Adjusted Book per Share too high?
IDEXX Laboratories' current Cyclically Adjusted Book per Share is €7.26. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Cyclically Adjusted Book per Share compare to A and NTRA?
IDEXX Laboratories' Cyclically Adjusted Book per Share of €7.26 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on IDEXX Laboratories and its competitors. IDEXX Laboratories's current Cyclically Adjusted Book per Share is €7.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (FRA:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €562.69, compared to a current price of €469.00 — trading 16.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is €7.26. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For IDEXX Laboratories (FRA:IX1), the current Cyclically Adjusted Book per Share is €7.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (FRA:IX1) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €469.00 is trading 16.7% below its estimated GF Value™ of €562.69. GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.

Key valuation signals for FRA:IX1:

  • Cyclically Adjusted Book per Share: €7.26
  • GF Value™: €562.69 vs. price of €469.00 (16.7% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the FRA:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score

Get the complete analysis for FRA:IX1

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€469.00
Price
€562.69
GF Value